This new anti-cancer drug will be attacking the mitochondria of cancer cells. They do this by inhibiting the enzyme mitochondrial RNA polymerase (POLRMT).
Differentiated tissues are said to be tolerant of the inhibition of this enzyme while rapidly proliferating cells are impacted more.
The compound was found to reduce tumor growth in mice.
Comments are closed.